New abstracts show the oral PCSK9 inhibitor cut LDL-C by 57% to 63% across PREVENT risk groups, with reductions maintained in an extension study.
|Articles|December 1, 1996
The American Journal of Managed Care
- November/December 1996
- Volume 2
- Issue 11
The Impact of Managed Care on Continuing Medical Education
Author(s)Robert S. Pyatt, MD
Advertisement
Articles in this issue
almost 30 years ago
The Year in Reviewalmost 30 years ago
Childhood Immunizations: Beyond HEDISalmost 30 years ago
Implementation of a Clinical Pathway for Cesarean Sectionalmost 30 years ago
Six HMOs in Search of a Study: Comments on Two Papers by Horn et alalmost 30 years ago
The Economic and Health-Related Quality of Life Impact of Epilepsyalmost 30 years ago
Telecomputing as a Tool to Increase Consumer Participation in Managed CareAdvertisement
Related to this article
As National Family Caregivers Month begins, AJMC presents coverage from PCOC's first-ever panel on caregiving, where participants discuss demands on family members who are the “eyes and ears” when patients receive CAR T, bispecific, or transplant treatments.
Patients on tegoprubart reported fewer transplant-related symptoms and better quality of life at 12 months than those on tacrolimus in phase 2 BESTOW.
Facing steep 2027 cost increases, employers are narrowing obesity drug coverage, while direct-to-employer models let them cap what they spend.
Mayo Clinic case-control study links higher birth weight and childhood obesity to greater non-Hodgkin lymphoma risk, while longer breastfeeding may lower odds.
AI in myeloproliferative neoplasms can grade marrow fibrosis and predict survival, but authors say prospective, outcome-focused trials are needed first.
A home-based oncology model using clear bagging is transformational for practices, protecting Medicare reimbursement and provider control, while lowering costs for patients, providers and payers
Costs of multimorbidity in older adults are climbing faster than its disability toll, and study authors say policy should look past single-disease programs.
Advertisement
Advertisement
Trending on AJMC
1
Four Major Idiopathic Pulmonary Fibrosis Advances From 2026
2
As Employers Pull Back on GLP-1s, Andel and Novo Offer a Workaround
3
Birth Weight, Childhood Weight Gain Linked to Non-Hodgkin Lymphoma Risk
4
Kidney Week 2026 Recap: IgAN Advances, Value-Based Care, CKD Care Gaps
5